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Cellular senescence is a stable proliferation arrest that suppresses tumorigenesis. Cellular senescence and
associated tumor suppression depend on control of chromatin. Histone chaperone HIRA deposits variant histone
H3.3 and histone H4 into chromatin in a DNA replication-independent manner. Appropriately for a DNA
replication-independent chaperone, HIRA is involved in control of chromatin in nonproliferating senescent cells,
although its role is poorly defined. Here, we show that nonproliferating senescent cells express and incorporate
histone H3.3 and other canonical core histones into a dynamic chromatin landscape. Expression of canonical
histones is linked to alternative mRNA splicing to eliminate signals that confer mRNA instability in non-
proliferating cells. Deposition of newly synthesized histones H3.3 and H4 into chromatin of senescent cells
depends on HIRA. HIRA and newly deposited H3.3 colocalize at promoters of expressed genes, partially
redistributing between proliferating and senescent cells to parallel changes in expression. In senescent cells, but
not proliferating cells, promoters of active genes are exceptionally enriched in H4K16ac, and HIRA is required for
retention of H4K16ac. HIRA is also required for retention of H4K16ac in vivo and suppression of oncogene-
induced neoplasia. These results show that HIRA controls a specialized, dynamic H4K16ac-decorated chromatin
landscape in senescent cells and enforces tumor suppression.
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Cellular senescence is a stable proliferation arrest asso-
ciated with an altered proinflammatory secretory path-
way (Salama et al. 2014). In response to acquisition of an
activated oncogene, primary human cells enter this pro-
liferation-arrested senescent state (oncogene-induced se-
nescence [OIS]). By imposing proliferation arrest, OIS acts
as a tumor suppressor mechanism (Braig et al. 2005; Chen
et al. 2005; Collado et al. 2005; Michaloglou et al. 2005).
Even in the absence of an activated oncogene, replicative
senescence (RS) places an upper limit on the proliferative
capacity of normal cells, also blocking tumor formation
(Cosme-Blanco et al. 2007; Feldser and Greider 2007). The
altered secretory program of senescent cells, comprised of
proinflammatory cytokines, chemokines, andmatrix pro-
teases (the senescence-associated secretory phenotype
[SASP]) (Krtolica et al. 2001; Acosta et al. 2008; Kuilman
et al. 2008), can also contribute to tumor suppression
by promoting clearance of some senescent cells by
the immune system (Xue et al. 2007; Kang et al. 2011;
Lujambio et al. 2013).
Extensive chromatin changes are apparent in senescent
cells, most obviously in the form of domains of compacted
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heterochromatin called senescence-associated hetero-
chromatin foci (SAHF) (Narita et al. 2003, 2006; Braig
et al. 2005; Zhang et al. 2005; O’Sullivan et al. 2010;
Chandra et al. 2012; Cruickshanks et al. 2013; De Cecco
et al. 2013; Sadaie et al. 2013; Shah et al. 2013). These and
other chromatin changes are thought to contribute to the
onset and maintenance of viable senescence-associated
proliferation arrest (Braig et al. 2005; Narita et al. 2006;
DiMicco et al. 2011; Benhamed et al. 2012; Cruickshanks
et al. 2013; Martin et al. 2013). Chromatin changes likely
also contribute to activation of the SASP in senescent
cells (Shah et al. 2013). Subunits of the SWI/SNF ATP-
dependent chromatin remodeling complex are targets of
mutation and inactivation in cancer (Wilson and Roberts
2011), and SWI/SNF is thought to contribute to tumor
suppression in part through induction of senescence
(Chai et al. 2005). In sum, several lines of evidence
indicate that chromatin of senescent cells contributes
to tumor suppression (Braig et al. 2005; Narita et al.
2006). However, the molecular basis of this is poorly
understood.
Specifically, SAHF have been suggested to contribute to
stable repression of proliferation genes and/or suppres-
sion of DNA damage signaling in senescent cells (Narita
et al. 2003; Zhang et al. 2007; DiMicco et al. 2011). Either
way, the apparent heterochromatinization of senescent
cells intuitively suggests that their compacted, stable
chromatin contributes to a senescence-mediated barrier
to tumor progression. In line with this view of relatively
static chromatin in senescent cells, compared with pro-
liferating cells, senescent cells synthesize less total
histone H3 and H4 (O’Sullivan et al. 2010). In fact, in
mammalian cells, the canonical DNA replication-depen-
dent histones—H2A, H2B, H3 (H3.1 and H3.2), and H4—
are each coded for by 10–15 genes located mostly in
clusters on chromosomes 1 and 6, and the corresponding
mRNAs are typically unstable in nonproliferating cells
(Marzluff et al. 2008). This is again consistent with the
view that chromatin in nonproliferating senescent cells
is a relatively fixed entity, intuitively suggestive of an
immobile barrier to tumor progression. However, the
extent of chromatin dynamics in senescent cells has not
been properly investigated.
Histone variant H3.3 contributes to nucleosome de-
stabilization (Jin and Felsenfeld 2007) and so is thought to
facilitate nucleosome dynamics associated with tran-
scription activation and ongoing transcription. Histone
H3.3 is enriched at nucleosomes at transcription start
sites (TSSs) of genes and at enhancers and gene bodies of
actively transcribed genes (Ahmad and Henikoff 2002; Jin
et al. 2009; Goldberg et al. 2010). H3.3 differs from
canonical histones H3.1 and H3.2 by four or five amino
acids and is expressed constitutively throughout the cell
cycle and in proliferating and nonproliferating cells from
two genes:H3F3A andH3F3B (Skene and Henikoff 2013).
The HIRA chaperone complex, comprised of HIRA/
UBN1/CABIN1, collaborates with histone-binding pro-
tein ASF1a to incorporate H3.3 into chromatin in a DNA
replication-independent manner (Ray-Gallet et al. 2002;
Tagami et al. 2004; Loppin et al. 2005). The HIRA protein
is required for deposition of histone H3.3 at active and
poised genes and enhancers (Goldberg et al. 2010; Ray-
Gallet et al. 2011; Pchelintsev et al. 2013). Accordingly,
HIRA is required for gene activation in some contexts
(Placek et al. 2009; Dutta et al. 2010; Yang et al. 2011) as
well as recruitment and function of polycomb complexes
at gene promoters and dynamic restoration of chromatin
after DNA damage repair (Adam et al. 2013; Banaszynski
et al. 2013). On the other hand, the HIRA complex and its
orthologs, together with histone H3.3, are also involved
in chromatin silencing (Sherwood et al. 1993; van der
Heijden et al. 2007). Importantly, several recent studies
have shown histone H3.3 to be a target of recurrent
missense mutations in human cancer, and transcription-
coupled methylation of histone H3.3 is also thought to be
tumor-suppressive (Schwartzentruber et al. 2012; Wu
et al. 2012; Wen et al. 2014; Zhu et al. 2014). Appropri-
ately for a DNA replication-independent chaperone,
HIRA is also involved in control of chromatin in non-
proliferating senescent cells (Zhang et al. 2005; Ye et al.
2007; Banumathy et al. 2009; Rai et al. 2011; Duarte et al.
2014). However, HIRA’s function in senescent cells is
poorly defined, and there is currently no direct evidence
for a role in tumor suppression.
Here we set out to better understand dynamic chroma-
tin regulation in nonproliferating senescent cells and the
role of HIRA in this process. We reveal chromatin in
senescent cells to be a dynamic landscape linked to
noncanonical regulation of histone mRNAs and excep-
tional marking by H4K16ac. The histone chaperone
HIRA is required for regulation of this landscape and also
for suppression of oncogene-induced neoplasia in amouse
model. This study points to shared roles of HIRA, histone
H3.3, and H4K16ac in both cellular senescence and tumor
suppression.
Results
The mRNAs encoding the canonical DNA replication-
dependent histones are generally regarded as unstable in
nonproliferating cells (Marzluff et al. 2008). Moreover,
compared with proliferating cells, senescent cells synthe-
size less total histone H3 and H4 (O’Sullivan et al. 2010).
We were surprised, therefore, when gene expression
microarray revealed that a subset of histone mRNAs
was apparently up-regulated in RS cells (senescence
confirmed by standard markers of senescence) (Fig. 1A;
Supplemental Data Set 1; Supplemental Fig. 1A,B). Close
examination showed that these are typically canonical
DNA replication-dependent histones from the HIST1
cluster on chromosome 6 but are also annotated in
Ensembl (hg19) to contain a noncoding second exon,
and the Affymetrix probes target this second exon (Sup-
plemental Data Set 2; Supplemental Fig. 1C). This second
exon lacks the specialized stem–loop that terminates the
canonical replication-dependent histone mRNAs to con-
fer instability in nonproliferating cells (Marzluff et al.
2008) but instead directs mRNA polyadenylation. In both
RS and OIS cells, we confirmed up-regulation of the
second exon of several of these noncanonical histone
HIRA mediates tumor suppression
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mRNAs (and two others that lacked second exon probes
on the array, HIST4H4 and HIST1H2BN) by quantitative
RT–PCR (qRT–PCR) and RNA sequencing (RNA-seq)
(Fig. 1B,C; Supplemental Data Sets 2, 3). Accumulation
of these alternative spliced polyadenylated histone tran-
scripts has been previously reported in some cancer cell
lines after treatment with ionizing radiation and on differ-
entiation of mesenchymal progenitor cells (Kari et al. 2013).
Moreover, we observed up-regulation of the second exon
in quiescent cells (Supplemental Fig. 1D), suggesting that
accumulation of alternative spliced polyadenylated his-
tone mRNAs occurs in other nonproliferating cells as
well as senescent cells.
RNA-seq also confirmed splicing of the first coding
exon to the second exon in senescent cells, based on some
reads spanning the two exons (Supplemental Fig. 1E).
Significantly, qRT–PCR and RNA-seq data showed that
the first exon of histone mRNAs spliced to a polyade-
nylated noncoding second exon was down-regulated less
in senescence than canonical single coding exon stem–loop
histone mRNAs, such as HIST1H2BM and HIST1H3B
(Fig. 1B,D,E; Supplemental Data Set 3). Interestingly, the
eight alternative-spliced histones include genes encoding
theH2A, H2B, andH4 subtypes but noH3 gene. However,
histone variant H3.3 is already known to be expressed in
nonproliferating cells (Urban and Zweidler 1983; Grove
and Zweidler 1984; Pantazis and Bonner 1984; Brown et al.
1985; Skene and Henikoff 2013). Indeed, substantial ex-
pression of genes encoding DNA replication-independent
histone variant H3.3—H3F3A and H3F3B—was retained
in RS and OIS cells (Fig. 1F; Supplemental Fig. 1F). This
suggests that the alternative-spliced mRNAs coding for
the canonical H2A,H2B, andH4 subtypes are counterparts
of histone variant H3.3 (Supplemental Data Sets 2, 3). We
conclude that senescent cells retain expression of a small
subset of the >40 canonical histone genes whose expres-
sion is typically classed as replication-dependent, linked to
alternative mRNA splicing to bypass a signal known to
direct mRNA degradation in nonproliferating cells.
Next, we investigated whether newly synthesized
histones are deposited into chromatin in senescent cells.
Previous studies have indicated that recruitment of his-
tone chaperones and histones to PML bodies is indicative
of trafficking of newly synthesized histones into chroma-
tin (Chang et al. 2013; Delbarre et al. 2013; Corpet et al.
2014). Consistent with ongoing histone deposition and
nucleosome assembly in nonproliferating senescent cells,
histone H3 was enriched in PML bodies of RS and OIS
Figure 1. Expression of histone mRNAs in senescent
cells linked to alternative mRNA splicing. (A) Expression
of multiple histone mRNAs assessed by Affymetrix
microarray in proliferating (Prolif) and RS cells (five
independent replicates of each). Gene expression is
scaled for each gene individually, and resulting intensi-
ties are plotted between the green (low) and red (high)
scale. (B) Fold change in abundance of first (coding) and
second (noncoding, poly A) exons of selected HIST1
cluster mRNAs between proliferating and RS cells,
determined by qRT–PCR. HIST1H2BM and HIST1H3B
(coding for canonical histone H2B and H3.1, respec-
tively) are expressed only as single-exon stem–loop
mRNAs. Values are means 6 standard deviation of
three independent experiments normalized to GAPDH
as a housekeeping control. (C) Exon read counts (reads
per kilobase of exon model per million mapped reads
[RPKM]) of single-exon (HIST1H4I and HIST1H2AH;
green) and two-exon (HIST1H2BK; first coding exon in
red and second noncoding exon in yellow) histone
mRNAs in proliferating, RS, control (Con), and OIS
cells. (D) Fold change in abundance of first coding exon
between proliferating and RS cells, comparing single-
exon, stem–loop, and no poly A mRNAs and those
mRNAs with a poly A second exon whose expression
increases in RS, as determined by RNA-seq. See Sup-
plemental Data Set 3 for gene lists. P-value = 0.0002016.
(E) As in D, but analysis performed in OIS. See Supple-
mental Data Set 3 for gene lists. P-value = 0.001837.
(F) Expression of H3F3A and H3F3B genes assessed by
RNA-seq in proliferating and RS cells.
Rai et al.
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cells, where it colocalized with DNA replication-indepen-
dent histone chaperone HIRA (Fig. 2A,B). While ectopi-
cally expressed epitope-tagged histone H3.3 was not
detectably cell cycle inhibitory or toxic to proliferating
or RS cells (Supplemental Fig. 2A), ectopically expressed
H3.3 and H4 were incorporated into detergent-insoluble
nuclear chromatin of senescent cells, directly demonstrat-
ing that newly synthesized histones can be incorporated
into chromatin in senescent cells (Fig. 2C; Supplemental
Fig. 2B). In contrast, DNA replication-dependent histone
variant H3.1 was incorporated into chromatin of
proliferating cells, but not senescent cells, despite com-
parable expression of ectopically expressed H3.1 mRNA
between proliferating and senescent cells (Fig. 2C,D).
Chromatin immunoprecipitation (ChIP) combined with
sequencing (ChIP-seq) of ectopically expressed HA-tagged
histone H3.3 in proliferating and RS cells confirmed that
its distribution between different genome features was
comparable with endogenous H3.3, as previously deter-
mined by Allis and coworkers (Goldberg et al. 2010)
(Fig. 2E; Supplemental Table 1). Incorporation of ectopi-
cally expressed histones into chromatin implies a level of
histone exchange in the chromatin of these senescent
cells. Consistent with this idea, fluorescence recovery
after photobleaching (FRAP) showed that a proportion of
ectopically expressed nuclear GFP-H3.3 recovered from
photobleaching within seconds (Fig. 2F). Together, these
analyses of endogenous and ectopic histones suggest that
histones H3.3 and H4 dynamically exchange at their
physiological sites of incorporation in senescent cells.
Given HIRA’s role in DNA replication-independent
histone H3.3 deposition, we set out to compare the
genomic distribution of HIRA and newly synthesized
histone H3.3 in proliferating and senescent cells. HIRA
ChIP-seq was performed on chromatin from proliferating,
RS, and OIS (and control) cells. Comparison of the HIRA
and histone H3.3 genome distribution from proliferating
and RS cells confirmed a substantial and highly signifi-
cant overlap of HIRA and H3.3 in both proliferating and
senescent cells (Supplemental Tables 1, 2). Consequently,
initial analyses were performed on the intersect of the
HIRA and H3.3 data sets (Supplemental Table 3). Consis-
tent with previous analyses, a large proportion of HIRA/
H3.3 peaks localized at and near coding regions (Supple-
mental Fig. 3A; Ahmad and Henikoff 2002; Jin et al. 2009;
Goldberg et al. 2010; Pchelintsev et al. 2013). In both
Figure 2. Dynamic incorporation of histones
into chromatin of senescent cells. (A) Prolifer-
ating (Prolif), RS, and OIS cells fluorescently
stained with antibodies to PML and histone H3.
(B) Proliferating, RS, and OIS cells fluorescently
stained with antibodies to HIRA and histone H3.
(C) RS cells were infected with lentivirus en-
coding HA-histone H4, HA-histone H3.3, and
HA-histone H3.1 and fluorescently stained with
anti-HA. (D) Cells from C were analyzed for
mRNA abundance of HA-histone H3.1 by qRT–
PCR. The bar chart displays the mean HA-H3.1
mRNA abundance in senescent cells compared
with proliferating cells, normalized to GAPDH as
a housekeeping control. Standard error from
three independent experiments. (E) Percentage
of base pairs covered by H3.3 peaks that overlap
with base pairs of specified genomic features
for human proliferating and RS cells expressing
ectopic HA-tagged H3.3 and mouse embryonic
stem cells expressing endogenous HA-tagged H3.3.
(F) The percentage of mobile fraction (Fm) and
half-time of recovery in seconds (T1/2) for histones
located in GFP-H3.3 foci (likely PML bodies, based
onA,B) and nucleoplasm. Error bars represent6SEM
from three independent experiments.
HIRA mediates tumor suppression
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proliferating and RS cells, HIRA/H3.3 peaks localized to
;10,000 coding regions (Supplemental Fig. 3B). Specific
enrichment was observed at CpG islands, promoters,
exons, and 59 untranslated regions (UTRs) (Supplemental
Fig. 3C). At promoters, HIRA and H3.3 were both most
enriched at the nucleosomes flanking the TSS, and for
HIRA in proliferating, RS, control, and OIS cells and H3.3
in proliferating and RS cells, binding correlated strongly
with gene expression, as determined by RNA-seq (Fig. 3A;
Supplemental Fig. 3D; Supplemental Table 4).
Since proliferating and senescent cells exhibit distinct
programs of gene expression, we asked whether changes
in gene expression between proliferating and senescent
cells correlated with change in HIRA and H3.3 binding.
For HIRA, a change in gene expression, either up or down,
directly correlated with a change in HIRA binding mea-
sured by ChIP (Fig. 3B) in both OIS and RS. Similarly, for
histone H3.3, an increase in expression directly corre-
lated with an increase in binding in RS (Fig. 3B; Supple-
mental Fig. 3E). Notably, 1919 genes acquired both HIRA
and H3.3 in senescent cells, and these are enriched in
genes related to TNF signaling, a component of the SASP
(Supplemental Fig. 3B; Supplemental Data Set 4; Coppe
et al. 2008). These correlations are also illustrated by a
comparison of the 250most up-regulated and down-regulated
genes (Supplemental Fig. 3E). However, across all genes,
a decrease in expression in senescence did not correlate
with decreased H3.3 binding, suggesting that genes that
are repressed on the transition from proliferating to RS
cells continue to incorporate histone H3.3 (Fig. 3B;
Supplemental Fig. 3E). These phenomena were most
marked at histone genes. Decreased expression of the
DNA replication-dependent histones in senescent cells
was accompanied by a marked decrease in HIRA binding
in both RS and OIS (Fig. 3C,D). However, H3.3 did not
substantially decrease at these genes in senescent cells
(Fig. 3D). In sum, HIRA and newly synthesized H3.3 are
localized to promoters of expressed genes in proliferating
and senescent cells and are partially relocalized between
proliferating and senescent cells, in line with changes in
gene expression—most notably in the case of HIRA at
DNA replication-dependent histone genes.
A recent study established a link between histone H3.3
and H4K16ac (Lin et al. 2013). Interestingly, H4K16ac also
has candidate tumor suppressor activity (Fraga et al. 2005;
Elsheikh et al. 2009). Therefore, to investigate this link
between HIRA/H3.3 and H4K16ac in tumor-suppressive
senescent cells, we performed ChIP-seq of H4K16ac in
Figure 3. Genome distribution of HIRA and histone
H3.3 between proliferating and senescent cells is regu-
lated in parallel with gene expression. (A) HIRA and
H3.3 enrichment profiles around (63 kb) the TSSs of the
top (red), middle (green), and bottom (blue) 1000 coding
genes ordered by expression for proliferating (Prolif), RS,
control (Con), and OIS cells. ChIP-seq signal was
normalized to input. (B) At significantly changing
coding genes (Benjamini and Hochberg false discover
rate 5%), the Pearson correlation coefficients (PCCs)
between the difference in ChIP-seq signal and the
difference in expression. ChIP-seq signals were calcu-
lated for promoter regions (TSS 62 kb) and normalized
to input. Differences in expression were calculated as
fold change (FC; log2). Differences were calculated from
proliferating to senescent cells (RS or OIS, as indicated).
The X-axis denotes the ChIP-seq data set used to
generate the PCCs. Bar colors indicate the gene sets
used for the comparison: all genes (All) and genes that
gain expression (Exp+), lose expression (Exp), gain
ChIP-seq signal (ChIP+), and lose ChIP-seq signal
(ChIP). An asterisk indicates significant correlation
at P < 0.05. (C) Scatter plot of single-exon, stem–loop, no
poly A (red diamonds), and two-exon poly A (black
diamonds) histone genes (Supplemental Data Set 3)
showing the difference in input normalized ChIP-seq
signal (TSS 6 2 kb) versus the difference in expression
(fold change log2) for proliferating to RS cells and
control to OIS cells. (D) Genome browser representa-
tion of HIRA, ribodepleted RNA, and H3.3 in prolifer-
ating and RS IMR90 cells at histone gene cluster one
(HIST1).
Rai et al.
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proliferating and RS cells using two different validated
antibodies to H4K16ac. There was a substantial and highly
significant overlap between the distribution of H4K16ac
detected by the two antibodies, particularly in RS cells (Fig.
4A; Supplemental Tables 1, 5, 6). For downstream analyses,
we evaluated the intersect of the two H4K16ac data sets.
Qualitatively, the overall distribution of H4K16ac across
the genome was similar for proliferating and RS cells and,
interestingly, was reminiscent of HIRA and histone H3.3.
H4K16ac was most abundant at the coding regions and
was enriched at CpG islands, promoters, and 59 UTRs
(cf. Supplemental Figs. 4A,B and 3A,C). However, both
antibodies reported a twofold to threefold increase in the
number of H4K16ac peaks and the number of base pairs
covered in RS cells (Fig. 4A; Supplemental Tables 5, 6).
Indeed,;45,000 regions showed an increase in H4K16ac in
RS, while <10,000 pre-existing peaks showed a decrease in
RS (Fig. 4B). On a larger scale, in RS cells, H4K16ac was
depleted from late replicating regions of the genome and
SAHF (Supplemental Fig. 4C,D), in line with incorporation
of late replicating regions into compacted SAHF, H4K16ac’s
ability to inhibit chromatin compaction, and a previous
report correlating global decreased H4K16ac to the forma-
tion of SAHF (Shogren-Knaak et al. 2006; Chandra et al.
2012; Contrepois et al. 2012).
There was a marked increase in overlap of HIRA/H3.3
and H4K16ac in RS cells (Fig. 4C), and H4K16ac peaks
acquired in RS mirrored HIRA/H3.3 peaks (Fig. 4D),
indicating a substantial increase in H4K16ac in RS at
regions bound by HIRA/H3.3. At H4K16ac peaks unique
to RS cells, the HIRA and H4K16ac enrichments by
ChIP-seq correlated strongly (Pearson correlation co-
efficient [PCC] = 0.64). Indeed, in RS cells but much
less so in proliferating cells, H4K16ac was enriched at
early replicating gene-rich regions (Fig. 4E; Supplemen-
tal Fig. 4C), particularly on either side of the TSS (Fig.
4F; Supplemental Fig. 4E). In senescent cells, ;12,500
genes were bound by H4K16ac, compared with <5000
genes in proliferating cells (Supplemental Fig. 4F). Re-
markably, in RS cells, H4K16ac was enriched at all
but the lowest expressed genes (Fig. 4F; Supplemental
Fig. 4E,G), and expressed genes gained H4K16ac in RS
cells compared with proliferating cells regardless of
whether their expression increased, decreased, or did
not change (Fig. 4G). These results show that in RS cells,
H4K16ac is an especially prominent feature at pro-
moters of expressed genes, where it colocalizes with
HIRA and newly synthesized H3.3. However, rather
than closely correlating with level of expression, an
abundance of H4K16ac registers a binary pattern, either
Figure 4. HIRA controls H4K16ac, a marker of
expressed genes in senescent cells. (A) The amount of
genome (in megabases) covered by H4K16ac peaks in
proliferating and RS cells, as determined by antibody
1 (Ab1), Ab2, and the intersection between the two Abs.
(B) The number of peaks that gain (up) or lose (down)
H4K16ac in RS cells compared with proliferating cells.
(C) The percentage of base pairs covered by both HIRA
and H3.3 peaks that overlap with base pairs covered by
H4K16ac peaks for proliferating and RS cells. (D) HIRA,
H3.3, and H4K16ac enrichment profiles centered on the
midpoint of intersected HIRA and H3.3 peaks (63 kb).
The ChIP-seq signal was normalized to input (HIRA,
H3.3) or H4 (H4K16ac). (E) Genome browser represen-
tative region (Chr11: 65,602,592–65,707,036, hg19)
showing HIRA, H3.3, and H4K16ac profiles in prolifer-
ating and RS cells. (F) H4K16ac enrichment profiles
around (63 kb) the TSSs of genes separated into
quartiles according to expression in proliferating (left)
and RS (right) (from high to low expression [Q1–Q4]).
ChIP-seq signal was normalized to H4. (G) Box plots
showing H4K16ac normalized to H4 ChIP-seq at pro-
moters of up-regulated (up), down-regulated (down),
unchanged, and unexpressed coding genes in RS cells
compared with proliferating cells. The bottom and top
of the boxes correspond to the 25th and 75th percen-
tiles, respectively, and the internal band is the median.
The plot whiskers correspond to the most extreme
value within 1.53 interquartile range.
HIRA mediates tumor suppression
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‘‘high’’ or ‘‘low,’’ linked to expressed or very low
expressed/off genes, respectively.
To directly test a requirement for HIRA in the deposi-
tion of histones and chromatin control in nonproliferating
senescent cells, we ectopically expressed HA-tagged
histone H3.3 and H4 in senescent cells infected with
a lentivirus encoding a control shRNA or shRNAs to
knock down HIRA. HIRA was knocked down in senes-
cent cells using two distinct lentivirus-encoded shRNAs
(Fig. 5A). HIRA blocked incorporation of histone H3.3 and
H4 into chromatin (Supplemental Fig. 5A,B), but this was
apparently largely due to a block to stable production of
the histone (Fig. 5A). Since knockdown of HIRA did not
affect histone HA-H3.3 mRNA expression (Fig. 5B),
binding to the HIRA chaperone is most likely required
for stability of the unincorporated histone substrate. We
also confirmed by liquid chromatography-mass spec-
trometry (LC-MS) analysis of histones purified from
heavy lysine pulse-labeled cells, either control or HIRA
knockdown, that HIRA is required for the incorporation
of newly synthesized endogenous histones H3 and H4
into chromatin but not H2A and H2B (Fig. 5C). Further-
more, while knockdown of HIRA did not affect the
number of PML bodies in senescent cells (Fig. 5D), it
did block recruitment of H3 protein to PML bodies
(Fig. 5E,F). Finally, proliferating and RS cells expressing
shRNAs to HIRA or a control were Western-blotted to
compare the abundance of core histones and a panel of
histone modifications. Previously, we and others reported
that cells held in a senescent state exhibit a progressively
decreased histone content (O’Sullivan et al. 2010; Ivanov
et al. 2013), as do aged yeast (Feser et al. 2010). Loss of
total core histones was exacerbated in cells lacking HIRA
(Fig. 5G; Supplemental Fig. 5C), consistent with a role for
HIRA in histone deposition during a cyclical eviction/
deposition process. More strikingly, compared with total
core histone, cells lacking HIRA showed a marked de-
crease in H4K16ac but no substantial change in a number
of othermodifications, includingH4K20me3 andH3K27me3
(Fig. 5G; Supplemental Fig. 5C). Together, these results
indicate that the HIRA chaperone is required for incor-
poration of histones H3.3 and H4 into chromatin in
senescent cells via a direct role in either histone de-
position into chromatin or the stability or trafficking of
non-chromatin-bound histones. Moreover, HIRA not
only colocalizes with H4K16ac across the genome of
senescent cells (Fig. 4) but is required for steady-state
abundance of H4K16ac in these cells. Thus, HIRA is
critical to control a specialized H4K16ac-decorated chro-
matin landscape in senescent cells.
Figure 5. HIRA histone chaperone is required for histone
and chromatin control in senescent cells. (A) RS cells were
infected with lentivirus encoding HA-histone H3.3 and
Western-blotted with the indicated antibodies. Mock-un-
infected lysate was used as a control. (SE) Short exposure;
(LE) long exposure. (B) Cells from A were analyzed for
mRNA abundance of HA-histone H3.3 by qRT–PCR. The
bar chart displays the mean HA-H3.3 mRNA abundance
in senescent cells compared with proliferating cells nor-
malized to GAPDH as a housekeeping control. Standard
error from three independent experiments. (C) Cells
infected with the indicated shRNAs were labeled for
48 h with medium containing heavy lysine (K8). Histones
were purified by acid extraction and gel purification and
digested with trypsin, and the percentage of incorporation
of heavy lysine (K8)—of total heavy and light (K0) lysine—
in histones was determined by quantitative proteomics.
(D) RS cells were infected with lentivirus-encoded
shRNAs to HIRA (shHIRA1 and shHIRA2) or control
(shLuc) and fluorescently stained with antibodies to
PML. (E) RS cells were infected with lentivirus-encoded
shRNAs to HIRA (shHIRA) or control (shLuc) and fluo-
rescently stained with antibodies to histone H3, PML, and
HIRA. (F) Quantitation of cells with H3 localized to PML
bodies from E. (G) Western blots of the indicated proteins
in control and shHIRA-infected proliferating and RS cells.
(Bottom) Ponceau S was used as an additional loading
control.
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In light of these findings and the known role of
senescence as a tumor suppressor mechanism, wewanted
to test the requirement for HIRA in suppression of neo-
plasia in vivo. To do this, we employed a mouse model
expressing a tamoxifen/b-naphthoflavone-induced onco-
genic Braf allele (LSL-BrafV600E) (Mercer et al. 2005)
controlled by an AhCreER promoter/transgene cassette
(Kemp et al. 2004). BrafV600E induces senescence in
mouse and human tissues, including melanocytes and
intestinal epithelium (Michaloglou et al. 2005; Dhomen
et al. 2009; Carragher et al. 2010). We also generated
a mouse harboring a conditionally inactivated Hira allele
(Hirafl.fl) in which Cre-mediated excision of loxP-flanked
exons 6 and 7 generates a stop codon in exon 8 (Supple-
mental Fig. 6A). While this setup directs endogenous
levels of expression of BRAFV600E and inactivation of HIRA
in a number of tissues, in this study, we focused on one
target of the AhCreER cassette: the skin (Clayton et al.
2007). On its own, expression of BRAFV600E induced hyper-
plasia of the skin epidermis, which was visible on micro-
scopic analysis of H+E-stained tissues but was typically
not apparent on examination of the shaved skin (Fig. 6A,B).
A small proportion (two out of 11) of these mice developed
papillomas (Supplemental Data Set 5). Remarkably, how-
ever, all 19 mice expressing activated BRAFV600E and
lacking HIRA developed rapidly growing papillomas that
reached the maximum permitted size (1.5 cm) within 2–3
wk, necessitating that they be culled (Fig. 6A–D, Supple-
mental Fig. 6B,C; Supplemental Data Set 5).
Histological analysis revealed marked hyperplasia in
the skin of induced AhCreER/LSL-BrafV600E/Hirafl.fl
mice (Fig. 6B; Supplemental Fig. 6B). The epidermal
keratinocytes of these mice continued to differentiate,
based on overt stratification, a thickened outer cornified
layer, and keratin pearls (Fig. 6B; Supplemental Fig. 6B,C).
The thickest hyperplastic areas sometimes showed
changes in K5 and K1 and cell enlargement. While this
suggested that the papillomas could progress to carci-
noma, at the age investigated, no invasion, disruption of
basement membranes, or other histological signs of carci-
noma were observed (Fig. 6B,E; Supplemental Fig. 6B).
Inactivation of HIRA on its own had no apparent effect
on skin histology or differentiation, at least over the 2- to
3-wk time frame (Supplemental Fig. 6D). In sum, com-
bined activation of BRAFV600E and inactivation of HIRA
causes rapid growth of well-differentiated nonmalignant
Figure 6. HIRA suppresses oncogene-induced neoplasia.
(A) Skin of representative wild-type (WT), AhCreER/LSL-
BrafV600E, and AhCreER/LSL-BrafV600E/Hirafl.fl mice
approximately 2 wk after tamoxifen treatment. (B)
H+E-stained sections of skin from the indicated mice
approximately 2 wk after tamoxifen treatment. (B)
Basement membrane location (also indicated by dashed
yellow line in wild type); (E) epidermis; (D) dermis; (HF)
hair follicle; (KP) keratin pearl. (C) Papilloma-associated
survival of control and AhCreER/LSL-BrafV600E/Hirafl.fl
mice after tamoxifen treatment (N = 19; seven male,
12 female) for AhCreER/LSL-BrafV600E/Hirafl.fl mice.
Controls include AhCreER/LSL-BrafV600E (N = 11;
three male, eight female; light green), AhCreER/Hirafl.fl
(N = 9; five male, four female; dark green), and AhCreER
(N = 12; eight male, four female; blue). Mice culled of
causes unrelated to papilloma formation were cen-
sored from analysis (indicated by ‘‘+’’ on the plot).
See Supplemental Data Set 5 for all mouse outcomes.
(D) Skin lesion area measured (length 3 width) at daily
intervals after tamoxifen treatment. N = 5 for AhCreER/
LSL-BrafV600E/Hirafl.fl (black); N = 2 for AhCreER/
LSL-BrafV600E (blue), neither of which developed any
skin lesion. In addition, AhCreER/LSL-BrafV600E (N = 2)
and AhCreER/LSL-BrafV600E/Hirafl.fl (N = 6) were treated
with corn oil and observed for 4 wk. None of the mice
developed any lesions or tumors. (E) Skin from mice of
the indicated genotypes ;2 wk after tamoxifen treat-
ment, stained with antibodies to keratin 1 and keratin 5.
Histological features labeled as in B. (OC) Outer corni-
fied layer. Bars, 100 mM.
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epidermal hyperplasias. We conclude that HIRA is re-
quired for efficient suppression of oncogene-induced neo-
plasia in vivo.
We asked whether HIRA’s role in suppression of neo-
plasia is linked to its regulation of chromatin structure
and senescence. Inactivation of HIRA alone did not
obviously affect proliferation or senescence markers
(Supplemental Fig. 7A). In control and induced AhCreER/
LSL-BrafV600E and AhCreER/LSL-BrafV600E/Hirafl.fl mice,
the level of cell proliferation, measured by BrdU
incorporation, correlated well with the degree of hyper-
plasia (Fig. 7). Consistent with the histologically differ-
entiated nature of the tissues, proliferation was largely
confined to the basal layer, although this layer was
expanded in induced AhCreER/LSL-BrafV600E/Hirafl.fl
mice (Fig. 7). Surprisingly, while we observed modest
induction of senescence markers p21 and p53 in induced
AhCreER/LSL-BrafV600E mice, expression of these pro-
teins was, in regions, more marked in induced AhCreER/
LSL-BrafV600E/Hirafl.flmice (Fig. 7; Supplemental Fig. 7B).
Most surprisingly, in mice harboring activated BRAFV600E
and inactivation of HIRA, there was a substantial overlap
of zones of proliferating cells marked by BrdU and zones
of cells expressing the highest levels of p21 and p53, with
all three enriched in the basal layer of the epidermis
(Fig. 7).
Inactivation of HIRA alone had no detectable effect on
total histone H3 or histone modifications H3K9me3,
H3K27me3, and H4K16ac (Supplemental Fig. 7C, cf.
with wild type in Fig. 7 and Supplemental Fig. 7D).
However, while inactivation of HIRA in induced AhCreER/
LSL-BrafV600E/Hirafl.fl mice did not overtly affect total
histone content and H3K9me3 and H3K27me3, papillo-
mas of induced AhCreER/LSL-BrafV600E/Hirafl.fl mice
were depleted of H4K16ac, particularly in the nonprolif-
erative regions furthest from the basal layer (Fig. 7;
Supplemental Fig. 7D). We conclude that, in the presence
of activated BRAFV600E, inactivation of HIRA expands
a population of cells that has engaged the p53–p21
senescence effector pathway yet remains in a proliferative
state. Moreover, inactivation of HIRA in vivo recapitu-
lates chromatin changes observed on HIRA inactivation
in senescent cells in vitro; most notably, decreased
H4K16ac.
Figure 7. Suppression of oncogene-induced neoplasia
by HIRA is linked to control of H4K16ac. Sections of
skin from the indicated mice ;2 wk after tamoxifen
treatment, stained with the indicated antibodies. Boxed
areas are expanded in Supplemental Figure 6B. Bars,
100 mM.
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Discussion
Cellular senescence acts as a barrier to malignant pro-
gression of potentially neoplastic cells (Salama et al.
2014), particularly those harboring activated oncogenes.
This barrier function is facilitated by the exceptional
stability of the senescence-associated proliferation arrest,
for example, in benign human nevi (Michaloglou et al.
2005). The mechanisms by which chromatin contributes
to barrier function are not fully understood. However,
most efforts to date have focused on features of chromatin
structure and regulation that promote compacted hetero-
chromatin, whose repressed ‘‘closed’’ state is intuitively
interpreted as a static barrier to proliferation and tumor
progression; for example, H3K9me3, HP1 proteins, and
SAHF (Braig et al. 2005; Narita et al. 2006). In contrast,
here we define chromatin of senescent cells as a dynam-
ically maintained landscape, exhibiting previously un-
anticipated dynamic features. We show that one critical
regulator of this dynamic landscape, histone chaperone
HIRA, is required for efficient suppression of oncogene-
induced neoplasia.
Several lines of evidence demonstrate the dynamic
nature of chromatin in senescent cells. First, histone
mRNAs are expressed in senescent cells. Second, in
senescent cells, histones are enriched in PML bodies.
This has been previously shown to reflect trafficking of
newly synthesized histones into chromatin (Chang et al.
2013; Delbarre et al. 2013; Corpet et al. 2014). Third,
newly synthesized ectopically expressed and endoge-
nous histones are actively incorporated into chromatin
in senescent cells. Fourth, FRAP analysis of a fluorescent-
tagged histone H3.3 demonstrates a highly mobile sub-
population of H3.3. Fifth, gene promoters in senescent
cells show marked relative enrichment of H4K16ac in
senescent cells. H4K16ac impedes higher-order chroma-
tin packaging (Shogren-Knaak et al. 2006) and has also
been suggested to directly promote nucleosome exchange
(Elliott et al. 2013). Together, these lines of evidence
indicate that chromatin of senescent cells is maintained
in a state of dynamic equilibrium.
Chromatin of senescent cells exhibits at least two
unanticipated specialized features, indicating its funda-
mentally distinct regulation from chromatin in prolifer-
ating cells. First, nonproliferating senescent cells do,
surprisingly, express a subset of so-called ‘‘replication-
dependent’’ histone genes, linked to alternative mRNA
splicing to a second exon harboring a polyadenylation
signal instead of a stem/loop structure. Presumably, this
second exon/poly A tail bypasses the normal stem–loop-
mediated degradation of these mRNAs in nonprolifer-
ating cells (Marzluff et al. 2008), facilitating their
preferential expression in senescent cells. Second,
H4K16ac is extraordinarily enriched at promoters of
expressed genes in senescent cells, even at genes that are
unchanged or decreased in expression compared with
proliferating cells. As a result, in senescent cells, but
not proliferating cells, H4K16ac appears to flag all
expressed genes, regardless of whether those genes are
expressed at a high or low level. Curiously, H4K16ac is
similarly enriched at promoters and enhancers of embry-
onic stem cells (Taylor et al. 2013), which have been
previously suggested to contain especially dynamic chro-
matin (Meshorer et al. 2006). H4K16ac has been reported
to counter heterochromatin spreading (Wang et al. 2013).
Conceivably, H4K16ac constitutes a local chromatin
‘‘barrier’’ to prevent promoter silencing in unusual chro-
matin environments in embryonic stem cells and senes-
cent cells.
We previously implicated the DNA replication-inde-
pendent histone chaperone HIRA and its binding partners
(UBN1, CABIN1, and ASF1a) in chromatin regulation in
senescent cells (Zhang et al. 2005; Banumathy et al. 2009;
Rai et al. 2011). Here, we directly demonstrate that
multiple features of the dynamic landscape in senescent
cells are controlled by HIRA. HIRA colocalizes with
histones in PML bodies of senescent cells, a presumptive
marker of HIRA-mediated trafficking of histones into
chromatin (Chang et al. 2013; Delbarre et al. 2013). HIRA
is required for the accumulation of histones in PML
bodies and also for the deposition and/or accumulation
of newly synthesized H3 (presumably H3.3) and H4 into
chromatin of senescent cells. HIRA also colocalizes with
newly deposited histone H3.3 at gene promoters in
senescent cells, particularly at highly expressed genes.
HIRA and, to a lesser extent, H3.3 alter their target gene
selection between proliferating and senescent cells, in
line with changes in expression. HIRA is required for the
retention of total histone content and, more specifically,
H4K16ac in senescent cells. HIRA also colocalizes with
H4K16ac at promoters of highly expressed genes. How-
ever, HIRA is unlikely to act alone in nucleosome dynam-
ics of senescent cells. An alternative chaperone, DAXX,
has previously been suggested to target histone H3.3 to
pericentromeric heterochromatin in senescent cells (Corpet
et al. 2014). A partially overlapping role for DAXX can
explain why repressed genes depleted of HIRA, such as
histone genes, continued to incorporate histone H3.3 in
senescent cells. Nonetheless, numerous lines of evidence
indicate that the HIRA chaperone complex is a critical
homeostatic regulator of the dynamic, H4K16ac-flagged
chromatin landscape of senescent cells.
While previous constitutive knockout animals showed
that HIRA is required for early embryo development
(Roberts et al. 2002; Szenker et al. 2012), these models
did not allow investigation of the functions in adult
tissues. Here, in a novel conditional knockout HIRA
mousemodel expressing an activated BRAFV600E oncogene
in the skin, inactivation of HIRA dramatically enhanced
oncogene-induced hyperplastic cell proliferation accompa-
nied by p53- and p21-expressing proliferating (BrdU+) cells,
consistent with impaired execution of the cellular senes-
cence program despite p53–p21 activation. Just as in vitro,
inactivation of HIRA also resulted in specific depletion of
H4K16ac. Inactivation of HIRA also appeared to modestly
impair differentiation in BRAFV600E-expressing epidermis,
based on altered K1 and K5 expression. Thus, both im-
paired differentiation and senescence likely contribute to
epidermal hyperplasia in AhCreER/LSL-BrafV600E/Hirafl.fl
mice. Regardless, these results indicate the importance
HIRA mediates tumor suppression
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of proper chromatin regulation for tumor suppression,
even in cells in which prosenescence effectors p53 and
p21 are activated. Remarkably, they also unambiguously
demonstrate a role for HIRA in efficient proliferation
arrest to suppress neoplasia in the face of an activated
oncogene.
Both histone H3.3 and H4K16ac are dysregulated in
cancer. The level of H4K16ac is reduced in many cancers
and cancer cell lines (Fraga et al. 2005; Elsheikh et al.
2009), suggesting a potential tumor suppressor function.
Recent studies have revealed recurrent missense muta-
tions in genes encoding histone H3.3 (H3F3A) and H3.1
(HIST3H1B) in some cancers, in particular in pediatric
gliomas (Schwartzentruber et al. 2012; Sturm et al. 2012;
Wu et al. 2012; Yuen and Knoepfler 2013). These muta-
tions often target specific residues and most often in
histone H3.3, specifically H3.3K27M and H3.3G34R/
V. The H3.3K27M protein acts as a dominant inhibitor
of the EZH2 histone methyltransferase responsible for
methylation of histone H3 to generate H3K27me3 (Lewis
et al. 2013). While H3.3K27M therefore acts to globally
reduce H3K27me3 levels, some regions do gain H3K27me3
(Chan et al. 2013; Lewis et al. 2013; Venneti et al. 2013). One
such region is reported to be the CDKN2a locus, encoding
the tumor suppressor p16INK4a, and expression of p16INK4a
is reduced in two glioma cell lines (Chan et al. 2013). The
p16INK4a/pRB pathway is a key effector of cellular
senescence, and its suppression by H3.3K27M would be
expected to impair senescence as a tumor suppressor
mechanism (Salama et al. 2014). Therefore, H3.3K27M
and inactivation of HIRA might in fact target similar
senescence-related pathways to promote tumorigenesis.
Perhaps more relevant to HIRA, very recent studies have
indicated that transcription-coupled methylation of H3
to yield H3K36me3 and, in particular, H3.3K36me3
exerts a tumor-suppressive function (Wen et al. 2014;
Zhu et al. 2014). HIRA is responsible for deposition of
histone H3.3 at many transcribed genes (Goldberg et al.
2010). Results reported here also invoke HIRA in the
maintenance of H4K16ac levels in senescent cells. Thus,
the tumor-suppressive functions of both histone H3.3 and
H4K16ac might be controlled by the HIRA chaperone
complex.
In sum, our description of specialized and dynamic
chromatin in senescent cells presents a new model for
chromatin control in senescent cells that is substan-
tially different from the intuitive model of more static
canonical heterochromatin enforcing a barrier to pro-
liferation and tumor progression. Histone chaperone
HIRA is a key regulator of this landscape and exhibits
potent neoplastic suppressor activity in a mouse model.
Extending this idea, we suggest that DNA replication-
independent chromatin regulators, such as HIRA, also
maintain the dynamic chromatin of senescent cells to
retain the tumor-suppressive nonproliferating phenotype
over the long term, a process that we refer to as chromatin
homeostasis or ‘‘chromostasis.’’ In future studies, it will
be important to investigate the extent to which HIRA,
histone H3.3, and H4K16ac act in concert to mediate
tumor suppression.
Materials and methods
See the Supplemental Material for additional methods, details,
and references.
Proliferating and senescent cells
IMR90 fibroblast cells were cultured according to American Type
Culture Collection guidelines in low oxygen (3%). Proliferating
fibroblasts (<30 population doublings) were cultured inDulbecco’s
modified Eagle’s medium supplemented with 20% (v/v) fetal
bovine serum until they reached RS (defined in Supplemental
Fig. 1A,B). To generate OIS and control cells, IMR90 cells stably
expressing a fusion protein of the estrogen receptor (ER) ligand-
binding domain and H-RASG12V (ER-RA-IMR90 cells [grown
phenol red-free]) (Barradas et al. 2009) were supplemented with
100 nM 4-hydroxytamoxifen (4-OHT) or ethanol vehicle,
respectively.
ChIP-seq
For HIRA ChIP, native ChIP was performed using benzonase
endonuclease for chromatin solubilization and fragmentation.
For HA-histone H3.3, H4K16ac, and H4 ChIP, cells were cross-
linked with 1% formaldehyde for 5 min at room temperature.
After quenching with glycine, the cells were harvested and
sonicated to produce soluble chromatin with DNA fragments
in the range of 300–500 base pairs. Fragmented chromatin was
incubated with antibodies to HIRA, HA, H4K16ac, or H4
preimmobilized on Dynabeads. Libraries were prepared from
10–20 ng of ChIP or input DNA using New England Biolabs
ChIP-seq kit according to the manufacturer’s instructions, and
the resulting libraries were sequenced on an Illumina GAIIx to
yield ;30 million to 40 million raw reads.
RNA-seq
RNAwas isolated using a Qiagen RNeasy kit. Ribodepletion was
performed using an Epicentre Ribo Zero kit (MRZH11124C).
Libraries were prepared according to the Illumina TruSeq pro-
tocol and sequenced on an Illumina GAIIx.
Massively parallel sequencing and data analysis
ChIP-seq or input reads were mapped to the human genome
(hg19) using the Bowtie 2 alignment software. Only unique reads
mapping to a single location were retained. The determination of
enriched regions was performed using the USeq and SICER
packages, and reads were visualized using the University of
California at Santa Cruz browser. The results presented were
analyzed from a single ChIP-seq reaction for HIRA in each of RS
and OIS and H3.3 in RS, but the results are representative of two
different experiments performed with two different antibodies
for H4K16ac.
LC-MS analysis of extracted histones
The extracted histones were separated by SDS-PAGE, digested
with trypsin, and analyzed by LC-MS on an AB-Sciex 5600 MS
system as described previously (Gabrielsen et al. 2013). Proteins
were identified by searching the UniProt database using Mascot
2.3 (MatrixScience), and SILAC ratios of lysine containing
peptides (K0/K8) were calculated using Mascot Distiller 2.5 run
on a local server.
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